$PG

The Procter & Gamble Company Q1 2027 Earnings Call Summary

Procter & Gamble reported Q1 2027 organic sales growth of 4.0%, driven by volume increases and strategic interventions. Market share improved in the U.S. and China, with the latter benefiting from competitive dynamics. The company maintained fiscal 2027 guidance for 1%-3% organic sales growth, despite a $1.4 billion after-tax headwind from raw materials and energy. Management expects sequential acceleration in sales growth and plans to offset costs through productivity gains and pricing actions.

Original reporting
Published Oct 22, 2026, 5:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 22, 2026, 5:53 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Procter & Gamble Company Q1 2027 Earnings Call Summary — source image
Decision brief

The 30-second read

$PGBearishMed
01

Why it matters

The guidance suggests limited organic growth and higher expenses, which may depress the stock in the near term.

02

Market read

The earnings guidance and cost outlook are material for investors tracking consumer staples and inflation exposure.

03

What to watch

Potential upside from the $90 M tariff refund and the newly acquired Thorne business.

Relevance 8/10Novelty 8/10Timing: after‑hours

Background

Procter & Gamble provided its Q1 earnings call summary, maintaining FY2027 guidance while outlining significant cost headwinds.

Company-level read

Ticker impact

$PGBearishMedium confidence
Context

Q1 2027 earnings call disclosed FY2027 organic sales growth guidance of 1%‑3% and $1.4‑1.9 B after‑tax cost headwinds, plus a $90 M tariff refund and a $1.4 B raw‑material price assumption.

Expected impact

likely pressure as investors price in weaker top‑line growth and elevated input costs

Evidence & confidence

The guidance range is below prior expectations and the disclosed cost headwinds are material for a consumer‑goods giant.

Market effects

Consumer staples may face broader margin pressure from rising commodity prices.

U.S. and Greater China consumer demand outlook tempered by cost inflation.

Highlights inflation‑driven challenges for multinational CPG firms.

Counterpoint

If the company can successfully pass cost pressures to consumers, earnings could beat the modest guidance.

Key entities

  • Procter & Gamble

    Consumer‑goods conglomerate reporting FY2027 outlook.

Related articles

$PGHighAI 9/10

Procter & Gamble Stocks Gain 5.62% on Volume-Led Quarter

Procter & Gamble (PG) reported a 4% sales increase to $23.3B in Q1, driven by volume growth. Shares rose 5.62% to $165.65. Earnings grew 1% to $1.97 per share, but higher costs impacted margins. Operating cash flow was $5.8B, supporting dividends and buybacks. The stock trades near its GF Value estimate.

$PGMedAI 8/10

P&G (PG) Q1 2027 Earnings Call Transcript

P&G (PG) reported Q1 2027 earnings with organic sales growth across all 10 product categories and 6 regions. North America and Europe grew 3% and 4% respectively, while Greater China saw 8% growth. Core EPS was $2, down 1 point YoY. The company maintained guidance for fiscal 2027 and highlighted successful product launches like Pantene's Abundant and Strong, Pampers Amoira, and Fairy Dish.

$PGHighAI 8/10

Procter & Gamble earnings analysis: questions answered and next catalysts

Procter & Gamble (PG) reported fiscal Q1 2027 earnings beating estimates with EPS of $2.00 and revenue of $23.28B. Organic sales grew 4.0%, and all categories and regions showed growth. However, margins fell due to rising commodity costs, and the company raised its cost-headwind estimate to $1.9B. The stock is trading at $166.58, near its 52-week high, with a market cap of $387B.

$PGHighAI 8/10

Procter & Gamble (PG) Reports Strong Q1 Results with Accelerated

Procter & Gamble (PG) reported Q1 results with core EPS of $2.00 and revenue of $23.28 billion, both exceeding estimates. Organic sales grew 4%, driven by volume and pricing. All product categories and regions saw growth, but margins declined due to rising costs. PG raised its FY27 commodity cost estimate to $1.4 billion. Management expects continued growth but warns of volatility.